Show simple item record

dc.contributor.authorLippke, Sen_US
dc.contributor.authorRinn, Ren_US
dc.contributor.authorDerksen, Cen_US
dc.contributor.authorDahmen, Aen_US
dc.date.accessioned2023-07-27T12:51:06Z
dc.date.available2023-03-15en_US
dc.date.issued2023-03-17en_US
dc.identifier.issn2076-393Xen_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/89821
dc.description.abstract(1) Background: Better understanding of post-/long-COVID and limitations in daily life due to the symptoms as well as the preventive potential of vaccinations is required. It is unclear whether the number of doses and timepoint interrelate with the trajectory of post-/long-COVID. Accordingly, we examined how many patients positively screened with post-/long-COVID were vaccinated and whether the vaccination status and the timepoint of vaccination in relation to the acute infection were related to post-/long-COVID symptom severity and patients' functional status (i.e., perceived symptom severity, social participation, workability, and life satisfaction) over time. (2) Methods: 235 patients suffering from post-/long-COVID were recruited into an online survey in Bavaria, Germany, and assessed at baseline (T1), after approximately three weeks (T2), and approximately four weeks (T3). (3) Results: 3.5% were not vaccinated, 2.3% were vaccinated once, 20% twice, and 53.3% three times. Overall, 20.9% did not indicate their vaccination status. The timepoint of vaccination was related to symptom severity at T1, and symptoms decreased significantly over time. Being vaccinated more often was associated with lower life satisfaction and workability at T2. (4) Conclusions: This study provides evidence to get vaccinated against SARS-CoV-2, as it has shown that symptom severity was lower in those patients who were vaccinated prior to the infection compared to those getting infected prior to or at the same time of the vaccination. However, the finding that being vaccinated against SARS-CoV-2 more often correlated with lower life satisfaction and workability requires more attention. There is still an urgent necessity for appropriate treatment for overcoming long-/post-COVID symptoms efficiently. Vaccination can be part of prevention measures, and there is still a need for a communication strategy providing objective information about the usefulness and risks of vaccinations.en_US
dc.languageengen_US
dc.relation.ispartofVaccines (Basel)en_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectSARS-CoV-2en_US
dc.subjectageen_US
dc.subjectbreakthrough infectionsen_US
dc.subjectlife satisfactionen_US
dc.subjectnumber of dosesen_US
dc.subjectperceived symptom severityen_US
dc.subjectsexen_US
dc.subjectsocial participationen_US
dc.subjecttimepointen_US
dc.subjectworkabilityen_US
dc.titlePatients' Post-/Long-COVID Symptoms, Vaccination and Functional Status-Findings from a State-Wide Online Screening Study.en_US
dc.typeArticle
dc.identifier.doi10.3390/vaccines11030691en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/36992274en_US
pubs.issue3en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume11en_US
dcterms.dateAccepted2023-03-15en_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States